Laxmi Organic Industries Ltd

Laxmi Organic Industries Ltd

₹ 154 1.71%
25 May - close price
About

Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited.
The company’s business operations are carried in over 30 countries including 11 offices located in India

Key Points

Product Portfolio[1]
a) Essentials Segment
The Segment includes products like Ethyl Acetate, Acetic Anhydride, Acetaldehyde, various solvents, ethanol, and n-Butyl/Ethyl Acetate. These cater primarily to the pharmaceutical, packaging, and industrial sectors.

  • Market Cap 4,283 Cr.
  • Current Price 154
  • High / Low 241 / 107
  • Stock P/E 54.0
  • Book Value 71.6
  • Dividend Yield 0.32 %
  • ROCE 4.69 %
  • ROE 4.08 %
  • Face Value 2.00

Pros

Cons

  • The company has delivered a poor sales growth of 9.99% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 5.67% over last 3 years.
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 8.64% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -3.15%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
730 729 652 694 792 718 771 786 710 693 700 719 735
672 652 613 642 702 647 697 712 651 662 663 669 682
Operating Profit 58 77 39 52 90 71 75 75 59 31 37 50 54
OPM % 8% 11% 6% 8% 11% 10% 10% 10% 8% 4% 5% 7% 7%
7 4 8 5 8 12 7 6 1 6 4 3 3
Interest -1 5 2 1 -1 3 8 2 7 5 6 7 5
Depreciation 23 21 28 28 31 26 27 31 40 17 20 20 19
Profit before tax 43 56 18 30 68 54 46 47 13 14 16 26 32
Tax % 43% 31% 39% 8% 35% 36% 39% 38% -64% -51% 29% 2% 34%
24 38 11 27 44 34 28 29 22 21 11 25 22
EPS in Rs 0.92 1.44 0.40 0.99 1.61 1.24 1.02 1.06 0.79 0.77 0.40 0.92 0.78
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
1,074 1,047 1,076 1,376 1,569 1,534 1,768 3,084 2,797 2,865 2,985 2,847
988 966 957 1,222 1,414 1,418 1,548 2,713 2,548 2,609 2,699 2,675
Operating Profit 86 80 119 154 155 117 220 371 248 256 286 171
OPM % 8% 8% 11% 11% 10% 8% 12% 12% 9% 9% 10% 6%
1 2 2 3 6 30 4 15 12 28 19 15
Interest 26 19 11 12 19 17 19 19 15 7 20 22
Depreciation 30 29 28 31 44 49 47 49 72 107 124 77
Profit before tax 31 34 82 113 98 81 158 318 173 171 161 88
Tax % 31% 22% 13% 33% 26% 13% 20% 19% 28% 29% 29% 10%
21 27 72 76 72 70 127 256 125 121 114 79
EPS in Rs 21.12 26.56 71.50 75.63 14.46 15.57 4.82 9.72 4.70 4.37 4.10 2.86
Dividend Payout % 0% 0% 0% 0% 0% 11% 10% 7% 11% 14% 12% 0%
Compounded Sales Growth
10 Years: 11%
5 Years: 10%
3 Years: 1%
TTM: -5%
Compounded Profit Growth
10 Years: 12%
5 Years: -9%
3 Years: -14%
TTM: -28%
Stock Price CAGR
10 Years: %
5 Years: -7%
3 Years: -15%
1 Year: -21%
Return on Equity
10 Years: 11%
5 Years: 9%
3 Years: 6%
Last Year: 4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 10 10 10 10 50 45 53 53 53 55 55 55
Reserves 199 225 295 369 400 382 982 1,248 1,359 1,742 1,851 1,930
249 221 104 215 175 159 149 139 406 143 258 543
152 176 240 300 389 484 654 825 595 887 880 917
Total Liabilities 610 632 649 895 1,014 1,069 1,838 2,265 2,412 2,827 3,045 3,446
226 215 202 293 346 338 325 394 715 879 1,166 1,481
CWIP 25 40 61 30 31 67 148 374 447 444 398 652
Investments 0 0 0 0 0 0 3 5 23 126 148 37
358 377 386 571 637 664 1,361 1,492 1,228 1,378 1,332 1,276
Total Assets 610 632 649 895 1,014 1,069 1,838 2,265 2,412 2,827 3,045 3,446

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
80 150 -7 188 196 106 46 199 561 108 175
-21 -37 -85 -123 -56 -641 95 -384 -490 -268 -404
-57 -107 85 -63 -123 527 -124 232 -42 90 247
Net Cash Flow 1 6 -7 2 16 -7 16 47 30 -70 18
Free Cash Flow 53 114 -95 90 118 -10 -243 -277 314 -286 -427
CFO/OP 90% 113% 13% 139% 181% 60% 27% 100% 234% 47% 108%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 64 67 79 86 76 86 90 79 74 74 66 67
Inventory Days 37 57 37 55 57 51 63 65 58 54 71 70
Days Payable 52 67 85 81 105 138 148 123 92 145 131 140
Cash Conversion Cycle 49 56 30 60 28 -1 5 21 41 -16 6 -3
Working Capital Days 65 66 36 28 28 17 -1 42 31 19 12 35
ROCE % 12% 22% 25% 19% 12% 20% 26% 11% 9% 9% 5%

Insights

In beta
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Dec 2025
Installed Capacity - Ethyl Acetate
MTPA

Log in to view insights

Please log in to see hidden values.

Login
Domestic Market Share - Diketene Derivatives (Specialties)
%
Domestic Market Share - Ethyl Acetate (Essentials)
%
Specific Steam Consumption (Ethyl Acetate)
MT/MT
Specific Electrical Energy Consumption (Ethyl Acetate)
kw/MT
Installed Capacity - Fluorospecialty (Lote Site)
MTPA
Number of Active Customers
Count
Number of Diketene Derivative Products
Count
Revenue Contribution from New Products (launched in last 5 years)
%
Total Volume Growth (Group)
%
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
72.39% 72.39% 69.83% 69.71% 69.55% 69.50% 69.39% 69.39% 69.38% 69.36% 69.36% 69.36%
0.48% 0.48% 0.67% 0.85% 1.05% 1.67% 1.97% 2.48% 1.63% 1.60% 1.60% 1.16%
1.54% 1.55% 3.53% 3.43% 2.16% 3.22% 3.47% 3.38% 4.05% 3.19% 3.40% 3.82%
25.59% 25.58% 25.97% 26.00% 27.25% 25.61% 25.17% 24.75% 24.93% 25.85% 25.65% 25.68%
No. of Shareholders 4,55,3374,52,2924,48,0684,28,1844,20,5093,87,4893,80,0593,76,1363,72,6413,62,1073,50,8993,40,436

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls